Shoosmiths advises on £37m sale of Global Group to Impellam Group plc

Shoosmiths advises on £37m sale of Global Group to Impellam Group plc


Author: Kara Shadbolt

National law firm Shoosmiths advised the sellers on the disposal of Global Group (UK) Ltd, a global healthcare business, to Impellam Group plc for an enterprise value of c.£37m.

Sanjeev Sharma

Justyn Randall, previously the CEO of Global Group, remains in the business and will become responsible for leading the business in Australasia. Ronan Corrigan, another key member of the management team, will also remain in the business and will be responsible for leading the business in Ireland.

Established in 2002, Global Group is a worldwide strategic staffing partner to the public and private healthcare sectors providing a range of recruitment and agency management solutions, specialising in locum doctors, with operations in the UK, Ireland, Australia, New Zealand and Canada.

Shoosmiths corporate partner, Sanjeev Sharma, led the deal with support from senior associate Iain Butler, associate Claire Checketts, trainee solicitor Aleksandr Bosch and paralegal James Grinstead. The corporate team were assisted by employment senior associate Simon Fennell and intellectual property solicitor, Jo Joyce.

Justyn Randall said: 'Shoosmiths were absolutely superb. Sanjeev and his team impressed us with their dedication and the extremely high level of service throughout the transaction. There were many shareholders and option holders to advise and the multi-jurisdictional element of the transaction required careful management.'

Sanjeev Sharma said: 'We have worked with Global Group for a number of years and it was a pleasure to guide the shareholders through the sale of their very successful business to Impellam.'

Shoosmiths' corporate team has advised public and private companies, management teams, investors and debt providers through the business life cycle. Shoosmiths work with businesses from start-up and first round finance through to mergers and acquisitions, MBO and MBI transactions, development funding and on exits, by way of sale, listing or private equity investment.

The national corporate team has been placed second by deal volume in Experian's UK Deal Review and Advisor League Table and have recently won Law Firm of the Year at the M&A Awards 2015.